Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Exome sequencing as a diagnostic tool in a case of undiagnosed juvenile-onset GM1-gangliosidosis.
[gm1 gangliosidosis]
To
utilize
high
-throughput
sequencing
to
determine
the
etiology
of
juvenile
-onset
neurodegeneration
in
a
19
-
year
-old
woman
with
progressive
motor
and
cognitive
decline
.
Exome
sequencing
identified
an
initial
list
of
133
,
555
variants
in
the
proband
's
family
,
which
were
filtered
using
segregation
analysis
,
presence
in
dbSNP
,
and
an
empirically
derived
gene
exclusion
list
.
The
filtered
list
comprised
52
genes
:
21
homozygous
variants
and
31
compound
heterozygous
variants
.
These
variants
were
subsequently
scrutinized
with
predicted
pathogenicity
programs
and
for
association
with
appropriate
clinical
syndromes
.
Exome
sequencing
data
identified
2
GLB
1
variants
(
c
.
602
G
>
A
,
p
.
R
201
H
;
c
.
785
G
>
T
,
p
.
G
262
V
)
.
β-
Galactosidase
enzyme
analysis
prior
to
our
evaluation
was
reported
as
normal
;
however
,
subsequent
testing
was
consistent
with
juvenile
-onset
GM
1
-
gangliosidosis
.
Urine
oligosaccharide
analysis
was
positive
for
multiple
oligosaccharides
with
terminal
galactose
residues
.
We
describe
a
patient
with
juvenile
-onset
neurodegeneration
that
had
eluded
diagnosis
for
over
a
decade
.
GM
1
-
gangliosidosis
had
previously
been
excluded
from
consideration
,
but
was
subsequently
identified
as
the
correct
diagnosis
using
exome
sequencing
.
Exome
sequencing
can
evaluate
genes
not
previously
associated
with
neurodegeneration
,
as
well
as
most
known
neurodegeneration
-associated
genes
.
Our
results
demonstrate
the
utility
of
"
agnostic
"
exome
sequencing
to
evaluate
patients
with
undiagnosed
disorders
,
without
prejudice
from
prior
testing
results
.
Diseases
Validation
Diseases presenting
"derived gene exclusion list. the filtered list"
symptom
gm1 gangliosidosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom